APO Research
Talk to an analyst

APO RESEARCH · REPORT

X-protein

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global X-protein Industry Growth and Trends Forecast to 2032

20 December 2025102 pages

Choose your research edition.

Industry ResearchX-protein Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal X-protein Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal X-protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal X-protein Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal X-protein Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global X-protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for X-protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for X-protein is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for X-protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of X-protein include Albumedix A/S, CSL Behring LLC, GRIFOLS INTERNATIONAL, S.A., HiMedia Laboratories, InVitria, Kedrion S.p.A, Medxbio Pte Ltd, Mitsubishi Tanabe Pharma Corporation and Octapharma AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global X-protein market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The X-protein market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global X-protein market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to X-protein.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global X-protein market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

X-protein Market by Company

Albumedix A/S

CSL Behring LLC

GRIFOLS INTERNATIONAL, S.A.

HiMedia Laboratories

InVitria

Kedrion S.p.A

Medxbio Pte Ltd

Mitsubishi Tanabe Pharma Corporation

Octapharma AG

Shire Plc. (Baxalta Inc.)

Sigma-Aldrich Co. LLC.

Thermo Fisher Scientific Inc

X-protein Segment by Type

Bovine Serum Albumin

Human Serum Albumin

Recombinant Albumin

X-protein Segment by Application

Drug Formulation and Vaccines

Blood Volumizer

Life Sciences

Others

X-protein Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global X-protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of X-protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of X-protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of X-protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of X-protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bovine Serum Albumin Table 2. Major Company of Human Serum Albumin Table 3. Major Company of Recombinant Albumin Table 4. Global X-protein Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global X-protein Sales by Type (2021-2026) & (W Tons) Table 6. Global X-protein Sales Market Share in Volume by Type (2021-2026) Table 7. Global X-protein Sales by Type (2021-2026) & (US$ Million) Table 8. Global X-protein Sales Market Share in Value by Type (2021-2026) Table 9. Global X-protein Price by Type (2021-2026) & (US$/Ton) Table 10. Global X-protein Sales by Type (2027-2032) & (W Tons) Table 11. Global X-protein Sales Market Share in Volume by Type (2027-2032) Table 12. Global X-protein Sales by Type (2027-2032) & (US$ Million) Table 13. Global X-protein Sales Market Share in Value by Type (2027-2032) Table 14. Global X-protein Price by Type (2027-2032) & (US$/Ton) Table 15. North America X-protein Sales by Type (2021-2026) & (W Tons) Table 16. North America X-protein Sales by Type (2021-2026) & (US$ Million) Table 17. Europe X-protein Sales by Type (2021-2026) & (W Tons) Table 18. Europe X-protein Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific X-protein Sales by Type (2021-2026) & (W Tons) Table 20. Asia-Pacific X-protein Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America X-protein Sales by Type (2021-2026) & (W Tons) Table 22. Latin America X-protein Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa X-protein Sales by Type (2021-2026) & (W Tons) Table 24. Middle East and Africa X-protein Sales by Type (2021-2026) & (US$ Million) Table 25. X-protein Industry Trends Table 26. X-protein Industry Drivers Table 27. X-protein Industry Opportunities and Challenges Table 28. X-protein Industry Restraints Table 29. Global X-protein Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global X-protein Revenue Market Share by Company (2021-2026) Table 31. Global X-protein Sales by Company (2021-2026) & (W Tons) Table 32. Global X-protein Sales Share by Company (2021-2026) Table 33. Global X-protein Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global X-protein Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global X-protein Major Company Production Sites and Headquarters Table 36. Global X-protein Company, Product Type & Application Table 37. Global X-protein Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global X-protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global X-protein Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global X-protein Sales by Region (2021-2026) & (W Tons) Table 42. Global X-protein Sales Market Share in Volume by Region (2021-2026) Table 43. Global X-protein Sales by Region (2021-2026) & (US$ Million) Table 44. Global X-protein Sales Market Share in Value by Region (2021-2026) Table 45. Global X-protein Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global X-protein Sales by Region (2027-2032) & (W Tons) Table 47. Global X-protein Sales Market Share in Volume by Region (2027-2032) Table 48. Global X-protein Sales by Region (2027-2032) & (US$ Million) Table 49. Global X-protein Sales Market Share in Value by Region (2027-2032) Table 50. Global X-protein Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global X-protein Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global X-protein Sales by Application (2021-2026) & (W Tons) Table 53. Global X-protein Sales Market Share in Volume by Application (2021-2026) Table 54. Global X-protein Sales by Application (2021-2026) & (US$ Million) Table 55. Global X-protein Sales Market Share in Value by Application (2021-2026) Table 56. Global X-protein Price by Application (2021-2026) & (US$/Ton) Table 57. Global X-protein Sales by Application (2027-2032) & (W Tons) Table 58. Global X-protein Sales Market Share in Volume by Application (2027-2032) Table 59. Global X-protein Sales by Application (2027-2032) & (US$ Million) Table 60. Global X-protein Sales Market Share in Value by Application (2027-2032) Table 61. Global X-protein Price by Application (2027-2032) & (US$/Ton) Table 62. North America X-protein Sales by Application (2021-2026) & (W Tons) Table 63. North America X-protein Sales by Application (2021-2026) & (US$ Million) Table 64. Europe X-protein Sales by Application (2021-2026) & (W Tons) Table 65. Europe X-protein Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific X-protein Sales by Application (2021-2026) & (W Tons) Table 67. Asia-Pacific X-protein Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America X-protein Sales by Application (2021-2026) & (W Tons) Table 69. Latin America X-protein Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa X-protein Sales by Application (2021-2026) & (W Tons) Table 71. Middle East and Africa X-protein Sales by Application (2021-2026) & (US$ Million) Table 72. Albumedix A/S Company Information Table 73. Albumedix A/S Business Overview Table 74. Albumedix A/S X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Albumedix A/S X-protein Product Portfolio Table 76. Albumedix A/S Recent Development Table 77. CSL Behring LLC Company Information Table 78. CSL Behring LLC Business Overview Table 79. CSL Behring LLC X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. CSL Behring LLC X-protein Product Portfolio Table 81. CSL Behring LLC Recent Development Table 82. GRIFOLS INTERNATIONAL, S.A. Company Information Table 83. GRIFOLS INTERNATIONAL, S.A. Business Overview Table 84. GRIFOLS INTERNATIONAL, S.A. X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. GRIFOLS INTERNATIONAL, S.A. X-protein Product Portfolio Table 86. GRIFOLS INTERNATIONAL, S.A. Recent Development Table 87. HiMedia Laboratories Company Information Table 88. HiMedia Laboratories Business Overview Table 89. HiMedia Laboratories X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. HiMedia Laboratories X-protein Product Portfolio Table 91. HiMedia Laboratories Recent Development Table 92. InVitria Company Information Table 93. InVitria Business Overview Table 94. InVitria X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. InVitria X-protein Product Portfolio Table 96. InVitria Recent Development Table 97. Kedrion S.p.A Company Information Table 98. Kedrion S.p.A Business Overview Table 99. Kedrion S.p.A X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Kedrion S.p.A X-protein Product Portfolio Table 101. Kedrion S.p.A Recent Development Table 102. Medxbio Pte Ltd Company Information Table 103. Medxbio Pte Ltd Business Overview Table 104. Medxbio Pte Ltd X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Medxbio Pte Ltd X-protein Product Portfolio Table 106. Medxbio Pte Ltd Recent Development Table 107. Mitsubishi Tanabe Pharma Corporation Company Information Table 108. Mitsubishi Tanabe Pharma Corporation Business Overview Table 109. Mitsubishi Tanabe Pharma Corporation X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Mitsubishi Tanabe Pharma Corporation X-protein Product Portfolio Table 111. Mitsubishi Tanabe Pharma Corporation Recent Development Table 112. Octapharma AG Company Information Table 113. Octapharma AG Business Overview Table 114. Octapharma AG X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Octapharma AG X-protein Product Portfolio Table 116. Octapharma AG Recent Development Table 117. Shire Plc. (Baxalta Inc.) Company Information Table 118. Shire Plc. (Baxalta Inc.) Business Overview Table 119. Shire Plc. (Baxalta Inc.) X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Shire Plc. (Baxalta Inc.) X-protein Product Portfolio Table 121. Shire Plc. (Baxalta Inc.) Recent Development Table 122. Sigma-Aldrich Co. LLC. Company Information Table 123. Sigma-Aldrich Co. LLC. Business Overview Table 124. Sigma-Aldrich Co. LLC. X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 125. Sigma-Aldrich Co. LLC. X-protein Product Portfolio Table 126. Sigma-Aldrich Co. LLC. Recent Development Table 127. Thermo Fisher Scientific Inc Company Information Table 128. Thermo Fisher Scientific Inc Business Overview Table 129. Thermo Fisher Scientific Inc X-protein Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 130. Thermo Fisher Scientific Inc X-protein Product Portfolio Table 131. Thermo Fisher Scientific Inc Recent Development Table 132. North America X-protein Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 133. North America X-protein Sales by Country (2021-2026) & (W Tons) Table 134. North America X-protein Sales Market Share by Country (2021-2026) Table 135. North America X-protein Sales Forecast by Country (2027-2032) & (W Tons) Table 136. North America X-protein Sales Market Share Forecast by Country (2027-2032) Table 137. North America X-protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America X-protein Market Size by Country (2021-2026) & (US$ Million) Table 139. North America X-protein Market Share by Country (2021-2026) Table 140. North America X-protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America X-protein Market Share Forecast by Country (2027-2032) Table 142. Europe X-protein Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 143. Europe X-protein Sales by Country (2021-2026) & (W Tons) Table 144. Europe X-protein Sales Market Share by Country (2021-2026) Table 145. Europe X-protein Sales Forecast by Country (2027-2032) & (W Tons) Table 146. Europe X-protein Sales Market Share Forecast by Country (2027-2032) Table 147. Europe X-protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe X-protein Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe X-protein Market Share by Country (2021-2026) Table 150. Europe X-protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe X-protein Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific X-protein Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific X-protein Sales by Country (2021-2026) & (W Tons) Table 154. Asia-Pacific X-protein Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific X-protein Sales Forecast by Country (2027-2032) & (W Tons) Table 156. Asia-Pacific X-protein Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific X-protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific X-protein Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific X-protein Market Share by Country (2021-2026) Table 160. Asia-Pacific X-protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific X-protein Market Share Forecast by Country (2027-2032) Table 162. Latin America X-protein Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 163. Latin America X-protein Sales by Country (2021-2026) & (W Tons) Table 164. Latin America X-protein Sales Market Share by Country (2021-2026) Table 165. Latin America X-protein Sales Forecast by Country (2027-2032) & (W Tons) Table 166. Latin America X-protein Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America X-protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America X-protein Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America X-protein Market Share by Country (2021-2026) Table 170. Latin America X-protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America X-protein Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa X-protein Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa X-protein Sales by Country (2021-2026) & (W Tons) Table 174. Middle East and Africa X-protein Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa X-protein Sales Forecast by Country (2027-2032) & (W Tons) Table 176. Middle East and Africa X-protein Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa X-protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa X-protein Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa X-protein Market Share by Country (2021-2026) Table 180. Middle East and Africa X-protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa X-protein Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. X-protein Distributors List Table 185. X-protein Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. X-protein Image Figure 2. Global X-protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global X-protein Market Size (2021-2032) & (US$ Million) Figure 4. Global X-protein Sales (2021-2032) & (W Tons) Figure 5. Bovine Serum Albumin Image Figure 6. Global Bovine Serum Albumin Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Human Serum Albumin Image Figure 8. Global Human Serum Albumin Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Recombinant Albumin Image Figure 10. Global Recombinant Albumin Sales YoY Growth (2021-2032) & (W Tons) Figure 11. Global X-protein Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global X-protein Market Share by Type 2025 VS 2032 Figure 13. North America X-protein Sales Market Share in Volume by Type in 2025 Figure 14. North America X-protein Sales Market Share in Value by Type in 2025 Figure 15. Europe X-protein Sales Market Share in Volume by Type in 2025 Figure 16. Europe X-protein Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific X-protein Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific X-protein Sales Market Share in Value by Type in 2025 Figure 19. Latin America X-protein Sales Market Share in Volume by Type in 2025 Figure 20. Latin America X-protein Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa X-protein Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa X-protein Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 X-protein Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Drug Formulation and Vaccines Image Figure 26. Global Drug Formulation and Vaccines Sales YoY Growth (2021-2032) & (W Tons) Figure 27. Blood Volumizer Image Figure 28. Global Blood Volumizer Sales YoY Growth (2021-2032) & (W Tons) Figure 29. Life Sciences Image Figure 30. Global Life Sciences Sales YoY Growth (2021-2032) & (W Tons) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 33. Global X-protein Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global X-protein Market Share by Application 2025 VS 2032 Figure 35. North America X-protein Sales Market Share in Volume by Application in 2025 Figure 36. North America X-protein Sales Market Share in Value by Application in 2025 Figure 37. Europe X-protein Sales Market Share in Volume by Application in 2025 Figure 38. Europe X-protein Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific X-protein Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific X-protein Sales Market Share in Value by Application in 2025 Figure 41. Latin America X-protein Sales Market Share in Volume by Application in 2025 Figure 42. Latin America X-protein Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa X-protein Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa X-protein Sales Market Share in Value by Application in 2025 Figure 45. North America X-protein Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 46. North America X-protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America X-protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America X-protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe X-protein Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 50. Europe X-protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe X-protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe X-protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific X-protein Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 54. Asia-Pacific X-protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific X-protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific X-protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America X-protein Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 58. Latin America X-protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America X-protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America X-protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa X-protein Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 62. Middle East and Africa X-protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa X-protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa X-protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. X-protein Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. X-protein Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Bovine Serum Albumin
  • Human Serum Albumin
  • Recombinant Albumin
Applications
  • Drug Formulation and Vaccines
  • Blood Volumizer
  • Life Sciences
  • Others
Companies covered
  • Albumedix A/S
  • CSL Behring LLC
  • GRIFOLS INTERNATIONAL, S.A.
  • HiMedia Laboratories
  • InVitria
  • Kedrion S.p.A
  • Medxbio Pte Ltd
  • Mitsubishi Tanabe Pharma Corporation
  • Octapharma AG
  • Shire Plc. (Baxalta Inc.)
  • Sigma-Aldrich Co. LLC.
  • Thermo Fisher Scientific Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global X-protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global X-protein Sales Estimates and Forecasts (2021-2032)
  5. 1.3 X-protein Market by Type
  6. 1.3.1 Bovine Serum Albumin
  7. 1.3.2 Human Serum Albumin
  8. 1.3.3 Recombinant Albumin
  9. 1.4 Global X-protein Market Size by Type
  10. 1.4.1 Global X-protein Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global X-protein Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global X-protein Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America X-protein Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe X-protein Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific X-protein Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America X-protein Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa X-protein Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 X-protein Industry Trends
  2. 2.2 X-protein Industry Drivers
  3. 2.3 X-protein Industry Opportunities and Challenges
  4. 2.4 X-protein Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by X-protein Revenue (2021-2026)
  2. 3.2 Global Top Players by X-protein Sales (2021-2026)
  3. 3.3 Global Top Players by X-protein Price (2021-2026)
  4. 3.4 Global X-protein Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global X-protein Major Company Production Sites & Headquarters
  6. 3.6 Global X-protein Company, Product Type & Application
  7. 3.7 Global X-protein Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global X-protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 X-protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 X-protein Tier 1, Tier 2, and Tier 3
4 X-protein Regional Status and Outlook
  1. 4.1 Global X-protein Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global X-protein Historic Market Size by Region
  3. 4.2.1 Global X-protein Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global X-protein Sales in Value by Region (2021-2026)
  5. 4.2.3 Global X-protein Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global X-protein Forecasted Market Size by Region
  7. 4.3.1 Global X-protein Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global X-protein Sales in Value by Region (2027-2032)
  9. 4.3.3 Global X-protein Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 X-protein by Application
  1. 5.1 X-protein Market by Application
  2. 5.1.1 Drug Formulation and Vaccines
  3. 5.1.2 Blood Volumizer
  4. 5.1.3 Life Sciences
  5. 5.1.4 Others
  6. 5.2 Global X-protein Market Size by Application
  7. 5.2.1 Global X-protein Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global X-protein Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global X-protein Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America X-protein Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe X-protein Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific X-protein Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America X-protein Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa X-protein Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Albumedix A/S
  2. 6.1.1 Albumedix A/S Company Information
  3. 6.1.2 Albumedix A/S Business Overview
  4. 6.1.3 Albumedix A/S X-protein Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Albumedix A/S X-protein Product Portfolio
  6. 6.1.5 Albumedix A/S Recent Developments
  7. 6.2 CSL Behring LLC
  8. 6.2.1 CSL Behring LLC Company Information
  9. 6.2.2 CSL Behring LLC Business Overview
  10. 6.2.3 CSL Behring LLC X-protein Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Behring LLC X-protein Product Portfolio
  12. 6.2.5 CSL Behring LLC Recent Developments
  13. 6.3 GRIFOLS INTERNATIONAL, S.A.
  14. 6.3.1 GRIFOLS INTERNATIONAL, S.A. Company Information
  15. 6.3.2 GRIFOLS INTERNATIONAL, S.A. Business Overview
  16. 6.3.3 GRIFOLS INTERNATIONAL, S.A. X-protein Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GRIFOLS INTERNATIONAL, S.A. X-protein Product Portfolio
  18. 6.3.5 GRIFOLS INTERNATIONAL, S.A. Recent Developments
  19. 6.4 HiMedia Laboratories
  20. 6.4.1 HiMedia Laboratories Company Information
  21. 6.4.2 HiMedia Laboratories Business Overview
  22. 6.4.3 HiMedia Laboratories X-protein Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 HiMedia Laboratories X-protein Product Portfolio
  24. 6.4.5 HiMedia Laboratories Recent Developments
  25. 6.5 InVitria
  26. 6.5.1 InVitria Company Information
  27. 6.5.2 InVitria Business Overview
  28. 6.5.3 InVitria X-protein Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 InVitria X-protein Product Portfolio
  30. 6.5.5 InVitria Recent Developments
  31. 6.6 Kedrion S.p.A
  32. 6.6.1 Kedrion S.p.A Company Information
  33. 6.6.2 Kedrion S.p.A Business Overview
  34. 6.6.3 Kedrion S.p.A X-protein Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kedrion S.p.A X-protein Product Portfolio
  36. 6.6.5 Kedrion S.p.A Recent Developments
  37. 6.7 Medxbio Pte Ltd
  38. 6.7.1 Medxbio Pte Ltd Company Information
  39. 6.7.2 Medxbio Pte Ltd Business Overview
  40. 6.7.3 Medxbio Pte Ltd X-protein Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Medxbio Pte Ltd X-protein Product Portfolio
  42. 6.7.5 Medxbio Pte Ltd Recent Developments
  43. 6.8 Mitsubishi Tanabe Pharma Corporation
  44. 6.8.1 Mitsubishi Tanabe Pharma Corporation Company Information
  45. 6.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview
  46. 6.8.3 Mitsubishi Tanabe Pharma Corporation X-protein Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mitsubishi Tanabe Pharma Corporation X-protein Product Portfolio
  48. 6.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
  49. 6.9 Octapharma AG
  50. 6.9.1 Octapharma AG Company Information
  51. 6.9.2 Octapharma AG Business Overview
  52. 6.9.3 Octapharma AG X-protein Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Octapharma AG X-protein Product Portfolio
  54. 6.9.5 Octapharma AG Recent Developments
  55. 6.10 Shire Plc. (Baxalta Inc.)
  56. 6.10.1 Shire Plc. (Baxalta Inc.) Company Information
  57. 6.10.2 Shire Plc. (Baxalta Inc.) Business Overview
  58. 6.10.3 Shire Plc. (Baxalta Inc.) X-protein Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shire Plc. (Baxalta Inc.) X-protein Product Portfolio
  60. 6.10.5 Shire Plc. (Baxalta Inc.) Recent Developments
  61. 6.11 Sigma-Aldrich Co. LLC.
  62. 6.11.1 Sigma-Aldrich Co. LLC. Company Information
  63. 6.11.2 Sigma-Aldrich Co. LLC. Business Overview
  64. 6.11.3 Sigma-Aldrich Co. LLC. X-protein Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sigma-Aldrich Co. LLC. X-protein Product Portfolio
  66. 6.11.5 Sigma-Aldrich Co. LLC. Recent Developments
  67. 6.12 Thermo Fisher Scientific Inc
  68. 6.12.1 Thermo Fisher Scientific Inc Company Information
  69. 6.12.2 Thermo Fisher Scientific Inc Business Overview
  70. 6.12.3 Thermo Fisher Scientific Inc X-protein Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Thermo Fisher Scientific Inc X-protein Product Portfolio
  72. 6.12.5 Thermo Fisher Scientific Inc Recent Developments
7 North America by Country
  1. 7.1 North America X-protein Sales by Country
  2. 7.1.1 North America X-protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America X-protein Sales by Country (2021-2026)
  4. 7.1.3 North America X-protein Sales Forecast by Country (2027-2032)
  5. 7.2 North America X-protein Market Size by Country
  6. 7.2.1 North America X-protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America X-protein Market Size by Country (2021-2026)
  8. 7.2.3 North America X-protein Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe X-protein Sales by Country
  2. 8.1.1 Europe X-protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe X-protein Sales by Country (2021-2026)
  4. 8.1.3 Europe X-protein Sales Forecast by Country (2027-2032)
  5. 8.2 Europe X-protein Market Size by Country
  6. 8.2.1 Europe X-protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe X-protein Market Size by Country (2021-2026)
  8. 8.2.3 Europe X-protein Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific X-protein Sales by Country
  2. 9.1.1 Asia-Pacific X-protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific X-protein Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific X-protein Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific X-protein Market Size by Country
  6. 9.2.1 Asia-Pacific X-protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific X-protein Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific X-protein Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America X-protein Sales by Country
  2. 10.1.1 South America X-protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America X-protein Sales by Country (2021-2026)
  4. 10.1.3 South America X-protein Sales Forecast by Country (2027-2032)
  5. 10.2 South America X-protein Market Size by Country
  6. 10.2.1 South America X-protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America X-protein Market Size by Country (2021-2026)
  8. 10.2.3 South America X-protein Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa X-protein Sales by Country
  2. 11.1.1 Middle East and Africa X-protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa X-protein Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa X-protein Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa X-protein Market Size by Country
  6. 11.2.1 Middle East and Africa X-protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa X-protein Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa X-protein Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 X-protein Value Chain Analysis
  2. 12.1.1 X-protein Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 X-protein Production Mode & Process
  7. 12.2 X-protein Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 X-protein Distributors
  10. 12.2.3 X-protein Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst